drugset
drugset / Trial / NCT03683953

The Treatment of Bronchopulmonary Dysplasia by Intratracheal Instillation of Mesenchymal Stem Cells

NCT03683953 ↗

Phase 1 Unknown 200 enrolled Guangdong Women and Children Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

To study the effect and saftey of intratracheal instillation of mesenchymal stem cells for treatment BPD

Timeline

Start
2018-09-29
Primary completion
2019-08-01
Completion
2020-07-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject mesenchymal stem cells Cell therapy 2.5e+07 cells/kg Other

Indications

No indication recorded.